Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(1)
Other(1)

Detailed Status

Enrolling by invitation1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 21 (50.0%)
N/A1 (50.0%)

Trials by Status

enrolling_by_invitation133%
unknown133%
withdrawn133%

Recent Activity

0 active trials
Showing 3 of 3
enrolling_by_invitation

Da Qing Offspring Study

NCT06958640
withdrawnnot_applicable

Home-based Prediabetes Care in Acoma Pueblo - Study 1

NCT04029298
unknownphase_2

Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients

NCT05914857

Clinical Trials (3)

Showing 3 of 3 trials
NCT06958640

Da Qing Offspring Study

Enrolling By Invitation
NCT04029298Not Applicable

Home-based Prediabetes Care in Acoma Pueblo - Study 1

Withdrawn
NCT05914857Phase 2

Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients

Unknown

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3